1. 四川省第二中医医院, 药剂科, 四川成都 610000
2. 成都市第三人民医院, 药剂科, 四川成都 610000
| 摘 要: | 目的:分析银杏内酯注射液致皮肤不良反应的临床特点,为其上市后安全性研究相关内容提供参考。方法:通过参与1例疑似银杏内酯注射液致皮肤不良反应的患者治疗过程,该患者因脑梗死给予银杏内酯注射液50mg静脉滴注、1次/d,连续2d,停药后6天,患者臀部出现皮疹,随后皮疹迅速扩散至全身,出现皮损伴有渗出倾向,皮肤瘙痒和广泛的表皮脱落,结合临床用药和此次不良反应的临床特点,从银杏内酯注射液的成分、银杏提取物的不良反应报道,分析银杏内酯注射液致皮肤不良反应的原因和机制。结果:经分析此次不良反应为银杏内酯注射液引起的严重皮肤过敏现象,在给予口服依巴斯汀、注射葡萄糖酸钙和维生素C、外用除湿止痒软膏治疗2周后,皮损基本愈合。结论:银杏内酯注射液引起的皮肤过敏性反应已有案例报道,但其安全性方面的临床试验研究仍缺乏药品上市后安全性研究相关内容,本次不良反应属于详细的个案分析,以期为银杏内酯注射液上市后安全性内容提供参考。 |
| 关 键 词: | 银杏内酯注射液; 泛发性湿疹; 严重药品不良反应 |
| DOI: | 10.57237/j.cmrd.2022.01.006 |
1. Pharmacy Department, Sichuan Second Hospital of T.C.M, Chengdu 610000, China
2. Pharmacy Department, Chengdu 610000, China
| Abstract: | Objective: To analyze the clinical characteristics of adverse skin reactions (ADRs) caused by ginkgolide injection, and to provide reference for the post-marketing safety study of ginkgolide injection. Methods: By participating in the treatment of a patient with suspected adverse skin reactions caused by ginkgolide injection, The patient was given target ginkgolide injection 50mg intravenously once a day for two consecutive days due to cerebral infarction. Six days after drug withdrawal, the patient developed a rash on the buttocks, and then the rash quickly spread to the whole body, resulting in skin lesions with exudation tendency, itchy skin and extensive epidermal shedding. Combined with clinical medication and the clinical characteristics of this adverse reaction, the causes and mechanisms of adverse reactions caused by ginkgolide injection were analyzed from the ingredients of ginkgolide injection and the adverse reaction reports of ginkgolide extract. Consults: The adverse reaction was analyzed as severe skin allergy caused by ginkgolide injection. After oral administration of ebastine, injection of calcium gluconate and vitamin C, and topical dehumidification and itching-relieving ointment, the skin lesions basically healed after 2 weeks. Conclusions: Cases of skin allergic reactions caused by ginkgolide injection have been reported, but clinical trials on the safety of ginkgolide injection still lack the content of post-marketing safety studies. This adverse reaction is a detailed case analysis, in order to provide reference for the content of post-marketing safety of ginkgolide injection. |
| Keywords: | Ginkgolide Injection; Generalized Eczema, Serious Adverse Drug Reactions |
| [1] | 季传平, 何纯, 李慧琴. 多中心评价银杏内酯注射液治疗重症缺血性脑卒中药物经济学 [J]. 药物评价研究, 2018, 41 (07): 1191-1195. |
| [2] | 徐露, 黄彦. 百裕银杏内酯注射液抑制家兔血小板聚集作用的实验研究[J]. 中国中医急症, 2014, 23 (04): 638-639+643. |
| [3] | 季传平, 徐露, 李慧琴. 银杏内酯注射液和银杏内酯ABC对血小板活化因子诱导的家兔血小板聚集作用比较 [J]. 药物评价研究, 2018, 41 (07): 1174-1178. |
| [4] | 孟甜甜, 解小龙, 李婷婷,等. 银杏内酯注射液辅助治疗急性缺血性脑卒中的系统评价与Meta分析 [J]. 世界中医药, 2021, 16 (08): 1241-1249. |
| [5] | 黄芳. 53例银杏内酯注射液不良反应报告分析 [J]. 中国合理用药探索, 2021, 18 (12): 23-27. |
| [6] | Naranjo, C. A, et al. A method for estimating the probabilty of adverse drug reaction [J]. Clinpharmacol Ther, 1981. 30 (2): p. 239-45. |
| [7] | 杨乐, 杜晓曦, 郭晓昕, 任经天, 沈璐, 宋海波. 银杏叶提取物注射液不良反应的文献分析 [J]. 中国药物警戒, 2014, 11 (03): 163-169. |
| [8] | 仝金凤.银杏达莫注射液静滴致严重皮肤过敏反应1例[J].中国社区医师(医学专业),2010,12(29):195. |
| [9] | 王基成. 银杏达莫注射液致过敏性皮疹2例 [J]. 中国医药指南, 2014, 12(02):192-193. |
| [10] | 陈建军. 银杏达莫注射液致类过敏反应1例 [J]. 甘肃中医药大学学报, 2017, 34 (03): 59-60. |
| [11] | 何静仁.银杏酸的变应原性及致过敏作用机制研究 [D]. 武汉: 华中农业大学, 2003. |
| [12] | Yanase Y, Takahagi S, Hide M. Chronic spontaneous urticaria and the extrinsic coagulation system. Allergol Int. 2018 Apr; 67 (2): 191-194. |
| [13] | 杨青波, 靳凤云, 陈伟, 姚鹏, 杜守颖.银杏达莫注射液中黄酮类和萜类内酯7种成分的定量测定 [J]. 中草药, 2014, 45 (22): 3279-3283. |
| [14] | 崔宏玉, 梁爱华. 从中药注射剂质量标准分析其不良反应成因 [J]. 中国中药杂志, 2014, 39 (05): 934-940. |
| [15] | 李邻峰. 中国湿疹诊疗指南 (2011年) 解读湿疹治疗: 控制症状, 减少复发, 提高患者生活质量 [J]. 中国社区医师, 2012, 28 (30): 7+10. |